Effect of ezetimibe in hypercholesterolemic patient with glucose tolerance
- Conditions
- Dyslipidemia
- Registration Number
- JPRN-UMIN000004091
- Lead Sponsor
- Chigasaki Municipal Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 150
Not provided
1)HbA1c>=9% 2)Patients with a history of hypersensitivity to any ingredient of ezetimibe tablets 3)Severe renal or hepatic disease 4)Having prior myocardial infarction or stroke 5)Patients with secondary hyperlipidemia or drug-associated hyperlipidemia 6)Patients who are pregnant or nursing mothers, patients who may be pregnant, or patients who want to become pregnant during participation in the study. 7)Familial hypercholesterolemia 8)Other patients deemed not appropriate for study entry by the investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The change of liipd levels(TC,TG,HDL-C,LDL-C,RLP-C)
- Secondary Outcome Measures
Name Time Method